About Allogene (ALLO)
Allogene Therapeutics, Inc. is a clinical stage immuno-oncology company. The Company is focused on developing and commercializing of allogeneic T cell therapies for the treatment of cancer. It is involved in developing a pipeline of multiple allogene... Read more
- USD1.29
- USD1.33
- USD1.25
- USD3.78
- -13.70%
- --
- 2.91M
- 2.87M
- 260M
- 0.86
- -47.30%
Stock News
8 hours ago
Are Tariffs Really Inflationary?
SeekingAlpha
yesterday
Cramer's week ahead: Earnings from JPMorgan, Netflix, Goldman Sachs and PepsiCo
CNBC
yesterday
Dow Jones Futures: Stocks Hold Up Amid Trump Tariffs, But Growth Woes Worrisome; Google, AMD Near Buy Points
Yahoo
yesterday
How Trump’s big bill makes it easier for all Americans to get a tax break for charitable donations — not just rich people
MarketWatch
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
